CardioFocus® Completes Successful Controlled U.S. Commercial Launch of the HeartLight® System

MARLBOROUGH, Mass., Nov. 29, 2017 /PRNewswire/ — CardioFocus, Inc. today announced the successful completion of its controlled U.S. commercial launch of the HeartLight® Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation (AF). Ten leading cardiac centers across the country have initiated HeartLight programs. The HeartLight System is a visually guided laser balloon technology for controlled […]

ZOLL and Myant Enter Strategic Research and Development Collaboration

CHELMSFORD, Mass. & TORONTO–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei Group company that manufactures medical devices and related software solutions, and Myant, Inc., a high-tech advanced manufacturing company that is pioneering the application of technology and soft electronics into textiles, today announced that they have entered an exclusive strategic multi-year agreement to […]

Medtronic Announces FDA Approval and U.S. Launch of Next Generation Pacemakers

DUBLIN – November 20, 2017 – Medtronic (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with BlueSync(TM)technology. Available in both single chamber and dual chamber models, the Azure XT MRI and Azure S MRI pacemakers offer improved longevity, estimated at 13.7 […]

LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million

LONDON & SHANGHAI–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, […]

Cardiac Insight Secures First Cardiology Customers for Its Wearable ECG Sensor, Cardea SOLO™

KIRKLAND, Wash.–(BUSINESS WIRE)– Cardiac Insight, a U.S. developer of wearable medical devices and diagnostic software, announced today that the company has secured its first cardiology customers for its wearable ECG sensor device, Cardea SOLO, in Texas and several other states. Early physician and patient experiences with Cardea SOLO are confirming the […]

EBR Systems, Inc. Raises $50 Million to Complete Global Heart Failure Trial

SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s first and only wireless cardiac pacing system for heart failure, has raised $50 million to conduct the global SOLVE-CRT study. The financing was led by Australian private equity firms M.H. Carnegie & Co. and Brandon Capital Partners and included participation by […]

BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

Santa Monica, CA, Nov. 14, 2017 (GLOBE NEWSWIRE) — BioSig Technologies(OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has engaged Tiffini Wittwer as Chief Regulatory and Compliance Officer […]

Aziyo Launches CanGaroo Bio Envelope for Subcutaneous Implantable Cardioverter-Defibrillators

SILVER SPRING, Md.–(BUSINESS WIRE)– Aziyo Biologics, a fully integrated regenerative medicine company, today announced the launch of a new CanGaroo Bio Envelope specifically for use with subcutaneous implantable cardioverter-defibrillators (S-ICDs). This is the only cardiac implantable electronic device (CIED) envelope available for use with S-ICDs. CanGaroo is a natural extracellular matrix (ECM) scaffold that […]

Five-year Follow-up Data Demonstrate the WATCHMAN™ Left Atrial Appendage Closure Device Provides Stroke Risk Reduction Comparable to Warfarin Therapy

DENVER and MARLBOROUGH, Mass., Nov. 2, 2017 /PRNewswire/ — Boston Scientific (NYSE: BSX) announced final five-year outcomes data from the PREVAIL study of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical trial session at the 29th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, in Denver. The […]

Imricor and MiRTLE Medical Announce Joint Development Agreement to Deliver 12-Lead ECG for Real-Time MRI-Guided Cardiac Ablations

MINNEAPOLIS–(BUSINESS WIRE)–Imricor and MiRTLE Medical announce a joint development agreement to fully integrate MiRTLE’s MR compatible 12-lead ECG system with Imricor’s Advantage-MR™ EP Recorder/Stimulator System. This integration, along with Imricor’s MR compatible catheters, will allow physicians to perform complex cardiac ablations, such as for treating ventricular tachycardia and atrial fibrillation, under real-time MRI-guidance. […]